A study published in The Annals of Family Medicine examined how different types of support for 32 primary care clinics ...

Rutgers has granted Tonix Pharmaceutical exclusive worldwide rights to develop and commercialize a novel class of compounds ...

Julie Blendy, professor of pharmacology at University of Pennsylvania’s Perelman School of Medicine, presented her research on the molecular and genetic mechanisms behind opioid use disorders in the ...

With an estimated 5 million Americans battling opioid use disorder—resulting in tens of thousands of deaths each year—a new ...

Researchers at USF Health are making dramatic strides in understanding how new opioid compounds work inside the body to provide pain relief, offering greater hope that new classes of these drugs may ...

Researchers have identified a new way to make opioids safer, increasing the pain-relieving properties of opioids while decreasing unwanted side effects through the spinal inhibition of a Heat shock ...

Pharmacology, prescribing requirements, and patient preference are crucial factors in choosing opioid agonist treatments.

Scientists are racing to redesign how powerful painkillers work, aiming to keep the relief that opioids provide while stripping away the worst dangers of addiction and overdose. Instead of tweaking ...

The pharmacology of naltrexone (Vivitrol, ReVia) is different from that of naloxone, even though they are both opioid antagonists. The differences between the two are the rate of onset and ...

Researchers at the University of Arizona Health Sciences identified a new way to make opioids safer, increasing the pain-relieving properties of opioids while decreasing unwanted side effects through ...